The Company focuses on developing drugs indicated for the treatment of cardiovascular system diseases, anti-tumor diseases, central nervous system diseases, blood system diseases, metabolism and digestive system diseases and anti-infection diseases and other treatment fields, and its main products occupy a leading position in their respective breakdown market.